PLEDPHARMA AB
6Patents
6Active
6Granted
45Portfolio score
Filing activity: Dec 12, 2008 → Feb 28, 2017 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9187509B2 | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment | Chemistry; Metallurgy | 3 | Active |
| US8377969B2 | Compounds for use in the treatment of cancer | Human Necessities | 2 | Active |
| US9597334B2 | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment | Chemistry; Metallurgy | 1 | Active |
| US10111893B2 | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment | Chemistry; Metallurgy | 0 | Active |
| US10688087B2 | Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound | Human Necessities | 0 | Active |
| US8633174B2 | Compounds for use in the treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.